Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-19-000752
Filing Date
2019-05-13
Accepted
2019-05-13 19:33:02
Documents
1
Period of Report
2019-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 19134
  Complete submission text file 0001123292-19-000752.txt   20501
Mailing Address C/O CURAGEN CORP 555LONG WHARF DR. 11TH FL. NEW HAVEN CT 06511
Business Address
SHANNON TIMOTHY M (Reporting) CIK: 0001207114 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38905 | Film No.: 19820102

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations